Space, the final frontier for drug stability says NASA study

By Gareth Macdonald

- Last updated on GMT

Related tags: Active pharmaceutical ingredient

Bowie: increasingly bored as the Odyssey went on
Bowie: increasingly bored as the Odyssey went on
The finding that space flight is detrimental to drug stability may have implications for drug packaging, dispensing technologies and mail order delivery according to a NASA study.

The research​, which compared the active pharmaceutical ingredient (API) content of 35 drugs stored on the international space station (ISS) with equivalents that remained on Earth, revealed that degradation accelerates as a function of time in space.

The team found that, after 596 days in space, only half (18 of 35) of the drugs tested met potency requirements, compared with 77 per cent of equivalents stored on Earth for that period. After 880 days in orbit only 31 per cent passed the potency test versus​ 54 per cent.

In addition to this the frequency of physical changes such as discolouration, liquefaction and phase separation observed in solid and semisolid dosages taken into space was also much higher than in terrestrial control samples.

The researchers also found that some drug were more suseptable to rapid degradation than others with, for example, the combination antibiotics sulfamethoxazole/trimethoprim and amoxicillin/clavulnate both losing potency faster in space than on earth.

Radiation and packaging

The scientists attributed the accelerated rate of degradation to the radiation dose the drugs were exposed to during space flight which, at 110.7 mGy, was many times higher than the average 5.45 mGy dose recorded on Earth.

The team also suggested that, aside the higher radiation exposure, the practice of repackaging the drugs taken into space in custom-manufactured polypropylene containers may have compromised stability.

"Research on new and emerging formulation and packaging technologies may enhance and ensure adequate shelf life of medications in space​."

Terrestrial relevance

This point was echoed by co-authour Lakshmi Putcha, from NASA’s Johnson Space Center who told in-Pharmatechnologist.com the findings will help ensure safe and efficient health care in space “if humans are determined to explore Mars and Venus​.”

Dr Putcha also said that, while the risk of radiation exposure is not directly relevant to the drug industry, the results “must be carefully evaluated with certain vulnerable ones [drugs] as they apply global market conditions and mail order meds.”

Related topics: Drug Delivery, Delivery technologies, QA/QC

Related news

Show more

Related products

show more

How to resolve sticking issues in tablet production

How to resolve sticking issues in tablet production

I Holland Limited - Tabletting Science | 24-Jun-2019 | Case Study

Tablet sticking is one of the most common problems in tablet manufacture. Find out how I Holland used the TSAR scientific predictive model and expert tablet...

How to measure powder and granule flow properties

How to measure powder and granule flow properties

Stable Micro Systems | 01-Apr-2019 | Technical / White Paper

Being able to predict, optimise and control powder flow is of prime importance to manufacturers in ensuring high quality standards. Download this free...

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Catalent Pharma Solutions | 22-Oct-2018 | Technical / White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Related suppliers

Follow us

Products

View more

Webinars